These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 30258502)

  • 41. Correlation between Systemic Lupus Erythematosus Disease Activity Index, C3, C4 and Anti-dsDNA Antibodies.
    Narayanan K; Marwaha V; Shanmuganandan K; Shankar S
    Med J Armed Forces India; 2010 Apr; 66(2):102-7. PubMed ID: 27365721
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinico-serological associations of urinary activated leukocyte cell adhesion molecule in systemic lupus erythematosus and lupus nephritis.
    Amer AS; Abdel Moneam SM; Hashaad NI; Yousef EM; Abd El-Hassib DM
    Clin Rheumatol; 2024 Mar; 43(3):1015-1021. PubMed ID: 38294724
    [TBL] [Abstract][Full Text] [Related]  

  • 43. High serum leptin and adiponectin levels as biomarkers of disease progression in Egyptian patients with active systemic lupus erythematosus.
    Kamel SM; Abdel Azeem Abd Elazeem MEMI; Mohamed RA; Kamel MM; Abdel Aleem Abdelaleem EA
    Int J Immunopathol Pharmacol; 2023; 37():3946320231154988. PubMed ID: 36718110
    [No Abstract]   [Full Text] [Related]  

  • 44. [Expression and Clinical Significance of Semaphorin 3A in serum and mononuclear cells in patients with systemic lupus erythematosus].
    Gao H; Ma XX; Guo Q; Zou YD; Zhong YC; Xie LF; Shao M; Zhang XW
    Zhonghua Yi Xue Za Zhi; 2017 Feb; 97(5):370-374. PubMed ID: 28219195
    [No Abstract]   [Full Text] [Related]  

  • 45. Erythrocyte C3d and C4d for monitoring disease activity in systemic lupus erythematosus.
    Kao AH; Navratil JS; Ruffing MJ; Liu CC; Hawkins D; McKinnon KM; Danchenko N; Ahearn JM; Manzi S
    Arthritis Rheum; 2010 Mar; 62(3):837-44. PubMed ID: 20187154
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Axl, Ferritin, Insulin-Like Growth Factor Binding Protein 2, and Tumor Necrosis Factor Receptor Type II as Biomarkers in Systemic Lupus Erythematosus.
    Mok CC; Ding HH; Kharboutli M; Mohan C
    Arthritis Care Res (Hoboken); 2016 Sep; 68(9):1303-9. PubMed ID: 26749069
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differential approach to peripheral blood cell ratios in patients with systemic lupus erythematosus and various manifestations.
    Suszek D; Górak A; Majdan M
    Rheumatol Int; 2020 Oct; 40(10):1625-1629. PubMed ID: 32772131
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Changes in platelet count and mean platelet volume during infectious and inflammatory disease and their correlation with ESR and CRP.
    Zareifar S; Farahmand Far MR; Golfeshan F; Cohan N
    J Clin Lab Anal; 2014 May; 28(3):245-8. PubMed ID: 24478177
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cytokine IL-6 and IL-10 as biomarkers in systemic lupus erythematosus.
    Chun HY; Chung JW; Kim HA; Yun JM; Jeon JY; Ye YM; Kim SH; Park HS; Suh CH
    J Clin Immunol; 2007 Sep; 27(5):461-6. PubMed ID: 17587156
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Correlation of Thyroid Autoantibodies,System Lupus Erythematosus Immunologic Indicators and Disease Activity in SLE with HT].
    Liu H; Yang LH; Yin G; Xie QB
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 Mar; 49(2):179-182. PubMed ID: 29737056
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Peak strain dispersion within the left ventricle detected by two-dimensional speckle tracking in patients with uncomplicated systemic lupus erythematosus.
    Li C; Li K; Yuan M; Bai W; Rao L
    Int J Cardiovasc Imaging; 2021 Jul; 37(7):2197-2205. PubMed ID: 33661409
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Urinary angiostatin, CXCL4 and VCAM-1 as biomarkers of lupus nephritis.
    Mok CC; Soliman S; Ho LY; Mohamed FA; Mohamed FI; Mohan C
    Arthritis Res Ther; 2018 Jan; 20(1):6. PubMed ID: 29325582
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Elevated Layilin-Positive Monocyte Levels in the Peripheral Blood of Patients with Systemic Lupus Erythematosus Reflect Their Autoimmune Status.
    Liu C; Wang Y; Zhang YH; Yuan Z; Zhang Z; Zeng X; Guan Z; Bahabayi A; Lu S
    Immunol Invest; 2023 Nov; 52(7):879-896. PubMed ID: 37642473
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Anti-lipoprotein lipase antibodies: a new player in the complex atherosclerotic process in systemic lupus erythematosus?
    de Carvalho JF; Borba EF; Viana VS; Bueno C; Leon EP; Bonfá E
    Arthritis Rheum; 2004 Nov; 50(11):3610-5. PubMed ID: 15529371
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association of systemic lupus erythematosus disease activity index score with clinical and laboratory parameters in pediatric onset systemic lupus erythematosus.
    Shamim R; Farman S; Batool S; Khan SEA; Raja MKH
    Pak J Med Sci; 2020; 36(3):467-472. PubMed ID: 32292454
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hyponatremia as an Inflammatory Marker of Lupus Activity Is a Fact or Fad: A Cross-Sectional Study.
    Yamany A; Behiry ME; Ahmed SA
    Open Access Rheumatol; 2020; 12():29-34. PubMed ID: 32210647
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The model of circulating immune complexes and interleukin-6 improves the prediction of disease activity in systemic lupus erythematosus.
    Thanadetsuntorn C; Ngamjanyaporn P; Setthaudom C; Hodge K; Saengpiya N; Pisitkun P
    Sci Rep; 2018 Feb; 8(1):2620. PubMed ID: 29422675
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serum free light chains as biomarkers for systemic lupus erythematosus disease activity.
    Aggarwal R; Sequeira W; Kokebie R; Mikolaitis RA; Fogg L; Finnegan A; Plaas A; Block JA; Jolly M
    Arthritis Care Res (Hoboken); 2011 Jun; 63(6):891-8. PubMed ID: 21312346
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Systemic lupus erythematosus disease activity and neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio: a cross-sectional case-control study.
    Abdalhadi S; Khalayli N; Al-Ghotani B; Kudsi M
    Ann Med Surg (Lond); 2023 May; 85(5):1448-1453. PubMed ID: 37229031
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ficolins and the lectin pathway of complement in patients with systemic lupus erythematosus.
    Hein E; Nielsen LA; Nielsen CT; Munthe-Fog L; Skjoedt MO; Jacobsen S; Garred P
    Mol Immunol; 2015 Feb; 63(2):209-14. PubMed ID: 25069872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.